Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Depreciation and Depletion (2016 - 2023)

Insight Molecular Diagnostics' Depreciation and Depletion history spans 4 years, with the latest figure at $404000.0 for Q3 2023.

  • On a quarterly basis, Depreciation and Depletion rose 3.32% to $404000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $1.8 million, a 32.55% increase, with the full-year FY2022 number at $1.5 million, up 81.04% from a year prior.
  • Depreciation and Depletion hit $404000.0 in Q3 2023 for Insight Molecular Diagnostics, down from $435000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for IMDX hit a ceiling of $466000.0 in Q4 2022 and a floor of -$216000.0 in Q4 2020.
  • Historically, Depreciation and Depletion has averaged $242733.3 across 4 years, with a median of $262000.0 in 2021.
  • Biggest five-year swings in Depreciation and Depletion: surged 269.57% in 2021 and later grew 3.32% in 2023.
  • Tracing IMDX's Depreciation and Depletion over 4 years: stood at -$216000.0 in 2020, then skyrocketed by 221.3% to $262000.0 in 2021, then soared by 77.86% to $466000.0 in 2022, then decreased by 13.3% to $404000.0 in 2023.
  • Business Quant data shows Depreciation and Depletion for IMDX at $404000.0 in Q3 2023, $435000.0 in Q2 2023, and $450000.0 in Q1 2023.